News
If you’ve been waiting for the chance for weight loss injections to drop in price, there are more options turning up to ...
Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...
In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...
Wall Street is getting worried about United Airlines. Yes, it's mostly about Newark airport. United has a major hub at Newark Liberty International Airport, and Wall Street wonders just how much the ...
A bill would allow Ohio state employees to purchase GLP-1s from manufacturers, then would require the Department of ...
A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...
Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.
It would behoove more Americans to learn how consistent seafood consumption has strong potential to ward off coronary disease ...
Uninsured or self-pay obesity patients can get any dose of Wegovy for $299 from July 1–31, 2025. Patients can get their ...
Novo Nordisk continues to expand its partnerships with telehealth companies to broaden access to its blockbuster weight loss ...
She began using Wegovy, the version of Ozempic approved for weight loss, after struggling with obesity. She reveals which foods to avoid on a GLP-1 and how to prevent muscle loss.
Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results